2026Eyl
ABT Sep 2026 · Reduce
Reduce. The report-date price of $105.52 stands above Fair value of $86.74, implying -17.8% to the central conclusion.Latest published research · analyzed 2026-09-09 · stale · sources stale
ABT · Archive
Daha önce yayımlanmış sürümleri, derecelendirmeleri ve fiyat eğilimlerini okuyun. Her satır kendi analiz tarihini belirtir.
USD 105,52
2026May
ABT May 2026 · Buy
Abbott Laboratories is a diversified, mature global healthcare leader characterized by stable free cash flows and a reliable dividend profile (67% payout ratio). Following a volatile pandemic-era revenue trajectory, the company is stabilizing into a moderate growth phase supported by its medical device and nutrition segments.Historical archived edition · analyzed 2026-05-09